Heiko Mühl
Zentrum der Pharmakologie
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main
Frankfurt am Main
Germany
Name/email consistency: high
- Interleukin-18 bioactivity: a novel target for immunopharmacological anti-inflammatory intervention. Mühl, H., Pfeilschifter, J. Eur. J. Pharmacol. (2004)
- The HIV protease inhibitor ritonavir synergizes with butyrate for induction of apoptotic cell death and mediates expression of heme oxygenase-1 in DLD-1 colon carcinoma cells. Mühl, H., Paulukat, J., Höfler, S., Hellmuth, M., Franzen, R., Pfeilschifter, J. Br. J. Pharmacol. (2004)
- Anti-inflammatory properties of pro-inflammatory interferon-gamma. Mühl, H., Pfeilschifter, J. Int. Immunopharmacol. (2003)
- Endothelial nitric oxide synthase: a determinant of TNFalpha production by human monocytes/macrophages. Mühl, H., Pfeilschifter, J. Biochem. Biophys. Res. Commun. (2003)
- Inhibition of lipopolysaccharide/ATP-induced release of interleukin-18 by KN-62 and glyburide. Mühl, H., Höfler, S., Pfeilschifter, J. Eur. J. Pharmacol. (2003)
- Nitric oxide augments release of chemokines from monocytic U937 cells: modulation by anti-inflammatory pathways. Mühl, H., Chang, J.H., Huwiler, A., Bosmann, M., Paulukat, J., Ninic, R., Nold, M., Hellmuth, M., Pfeilschifter, J. Free Radic. Biol. Med. (2000)
- Expression and release of chemokines associated with apoptotic cell death in human promonocytic U937 cells and peripheral blood mononuclear cells. Mühl, H., Nold, M., Chang, J.H., Frank, S., Eberhardt, W., Pfeilschifter, J. Eur. J. Immunol. (1999)
